PIRAMAL PHARMA
Back to Cashflow Statement
|
PIRAMAL PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-39 Cr | ₹-441 Cr | ₹-422 Cr | ₹818 Cr | ₹794 Cr |
What is the latest Cash Flow from Financing Activities ratio of PIRAMAL PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-39 Cr |
| Mar2025 | ₹-441 Cr |
| Mar2024 | ₹-422 Cr |
| Mar2023 | ₹818 Cr |
| Mar2022 | ₹794 Cr |
How is Cash Flow from Financing Activities of PIRAMAL PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-39 Cr | Negative | |
| Mar2025 | ₹-441 Cr | Negative | |
| Mar2024 | ₹-422 Cr | Negative | |
| Mar2023 | ₹818 Cr | 2.97 | |
| Mar2022 | ₹794 Cr | - | |
Compare Cash Flow from Financing Activities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹27,877.4 Cr | 5.2% | 21.8% | 5.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 5.2% |
21.8% |
5.7% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses